Hamptons Medical Weight Loss Doctor – Logo

Our practice is one of very few New York board certified providers that offer compounded tirzepatide for medical weight loss, as the nationwide shortage of the medication has put a strain on its availability.

NEW YORK (PRWEB)
May 18, 2023

Medical director and founder of the Southampton, NY based Hamptons Medical Weight Loss Doctor, Dr. Sue Decotiis, announced today that her specialty medical weight loss practice has noted a surge in men and women seeking Mounjaro™ (also known by its generic sister name tirzepatide) one-weekly injectable peptide therapy for medical weight loss. Mounjaro™ is FDA-approved to treat overweight / obese individuals, as well as individuals affected by type 2 diabetes.

According to a study published in the New England Journal of Medicine: “With the use of the efficacy estimated at 40 weeks, greater reductions in the fasting serum glucose level were observed with all tirzepatide doses than with semaglutide. In addition, all the tirzepatide doses resulted in greater reductions than those with semaglutide in the patient-measured mean blood glucose levels at all seven time points”, meaning patients who received weekly tirzepatide injections and practiced healthy lifestyle choices were able to lose sufficient weight compared to those who underwent semaglutide injections, alternatively.

“Our practice is one of very few New York board certified providers that offer compounded tirzepatide for medical weight loss, as the nationwide shortage of the medication has put a strain on its availability,” the triple board certified medical weight loss specialist, Dr. Sue Decotiis observed. Patients with type 2 diabetes and obesity have a long history of managing their weight successfully with the help of the GLP-1 receptor agonist.

Due to widespread isolation brought on by the COVID-19 epidemic, an increase in people seeking Mounjaro® weight loss counseling can be attributed to this worldwide health crisis. Many Americans adopted a dramatic and prolonged inactive lifestyle. The National Institute of Health states that psychological distress, pre-pandemic weight status, having children at home, and the amount of time since the last bodyweight check were statistically significant predictors of pandemic weight gain.

About Us

The board certified Hamptons weight loss specialist doctor offers prescriptions for medical weight loss including Mounjaro, Ozempic, Semaglutide, and Tirzepatide. Peptide therapy for weight loss is also offered including AOD-9604 (Advanced Obesity Drug), CJC-1295 / Ipamorelin, and Tesofensine. Hamptons Medical Weight Loss Doctor, specializing in weight loss treatments, is spearheaded by the best in class triple board certified medical weight loss doctor, Sue Decotiis, MD.

Hamptons Medical Weight Loss Doctor frequently treat treats patients from South Hampton, Bridgehampton, East Hampton, Hampton Bays, Montauk, Sag Harbor, Watermill, Southampton, West Hampton, and Quogue.

Hamptons Medical Weight Loss Doctor

53 Hill Street

Suite 104

Southampton, NY 11968

(631) 910-7185

https://www.hamptonsmedicalweightlossdoctor.com

Share article on social media or email:

As we seek to digitally transform healthcare, we are continuously in pursuit of creating state-of-the-art technology that improves the experience of dental professionals and patients alike.

BOSTON (PRWEB)
May 18, 2023

Revolutionary innovation continues at Bola Technologies, Inc. (Bola AI), as the leading provider of voice technology for healthcare and dental professionals is set to become the first company to implement generative AI and LLMs into its dental patient charting notes solution. The solution is expected to become available later this year.

The generative AI addition to Bola’s Clinical Notes software is designed to help turn tedious tasks into simple, quick engagements through AI. It allows for a fast, accurate voice transcription, freeing up dentists, hygienists and front-office staff to better serve the needs of patients by alleviating hours previously spent on note-taking and patient charting.

“The future of speech artificial intelligence is here,” said Rushi Ganmukhi, founder and CEO of Bola AI. “As we seek to digitally transform healthcare, we are continuously in pursuit of creating state-of-the-art technology that improves the experience of dental professionals and patients alike. Adding human-in-the-loop AI capabilities to our software is the next step toward developing a truly touchless environment for dental practices. One of the most powerful aspects of AI is personalization, allowing providers to use their personal workflow on a general product.”

Dental health practices that leverage Bola AI’s Clinical Notes software can realize the following benefits:

• 
  Creating convenience and standardization in workflow.
• Enabling more quality time with patients.
• Eliminating the need to scribble notes between appointments.
• Dictating common workflows by working with PMs templates.
• Using standardized templates for insurance and documentation purposes.
• Alleviating work after hours by making note dictation quicker.

Clinical Notes — available now for use with any practice management software — works with or without Bola AI’s Voice Perio system, which enables dental staff to seamlessly record periodontal data directly into client PMs and EHR systems in real time. Clinical Notes is trained on dental vocabulary, improves its AI use over time and can be used with any desktop-based EHR.

“At Bola AI, our focus is to make time-consuming tasks easier and more efficient,” says Ganmukhi. “Introducing generative AI into our Clinical Notes software accomplishes those goals and helps practices drive additional revenue while reclaiming extra time in the process.”

Tap into the latest innovation and cutting-edge AI technology for your dental practice by partnering with Bola AI today.

About Bola AI

Bola AI is the leader in Voice AI software for the dental practice. By harnessing the power of advanced technologies, this platform can provide efficient, fully integrated and accurate speech (99%) solutions for periodontal charting, clinical notes and more. With Bola AI, practices can empower themselves to create a smarter patient experience while improving operational efficiency and driving revenue. Headquartered in Boston, MA, Bola AI partners with Dentrix and Dentrix Ascend, Curve, Patterson and more. For more information, visit bola.ai.

Share article on social media or email:

“Whether you are an institutional investor, a day trader looking to diversify your portfolio or a healthcare professional keeping tabs on the industry, our advanced biotech investing tools and resources will deliver significant value.”—says Kris Kagan, SVP, BioPharmCatalyst.

SAN DIEGO (PRWEB)
May 18, 2023

BioPharmCatalyst (BPC), a division of Scientist.com, announced today that it has expanded the suite of digital tools it provides biotech investors and other life science professionals. The company’s new Elite plan gives users access to BPC’s core services and a wide range of new features, including data on historical probabilities of clinical trial success, insider trading activities, mergers and acquisitions as well as a detailed biotech conference calendar. BPC now also provides data and analytics on private biotech companies not yet publicly traded. Larger users such as venture capitalists, growth equity investors and private equity investors can access most of this data through BPC’s new Application Programming Interface (API), allowing seamless integration of BPC’s rich data into their existing workflows.

“We’re excited to unveil BioPharmCatalyst Elite in addition to access to our API, which provides our subscriber base with a wealth of new site features and easy access for businesses that want to integrate our data into their everyday processes,” says Kris Kagan, SVP, BioPharmCatalyst. “Whether you are an institutional investor, a day trader looking to diversify your portfolio or a healthcare professional keeping tabs on the industry, our advanced biotech investing tools and resources will deliver significant value.”

BPC provides indispensable tools to anyone interested in investing in the biotech industry. It helps investors make well-informed decisions based on the most recent corporate updates and clinical trial results. The newly released API facilitates real-time data retrieval from various endpoints, such as the FDA calendar, PDUFA calendar, Historical FDA calendar and Company & CEO screener.

BPC is currently offering a discounted Elite subscription rate as part of its Annual Sale. To register for a free or paid account, visit https://www.biopharmcatalyst.com/sign-up?source=landiing. For more information on API access, email contact@biopharmcatalyst.com.

About Scientist.com

BioPharmCatalyst is a division of Scientist.com, the biopharma industry’s largest marketplace for R&D services. The company’s digital research platform enables biopharma researchers to carry out more innovative experiments in less time and at lower cost. Scientist.com connects the world’s top pharmaceutical companies, biotechnology companies and the US National Institutes of Health (NIH) to the world’s largest network of scientific suppliers.

Share article on social media or email:

Men, women, and even children can experience hair loss. It can be emotionally difficult to lose hair, whether temporary or permanent.

FORT LAUDERDALE, Fla. (PRWEB)
May 18, 2023

The TV series Empowered with Meg Ryan highlights hair loss causes and treatments in an upcoming program. The episode will share advanced innovations in hair loss and expert insight.

Empowered is an educational documentary series shedding light on significant stories impacting consumers worldwide.

Producers from Empowered with Meg Ryan collaborated with relevant groups specializing in hair loss to secure content for the program.

Some hair loss is typical, with most individuals losing some hair daily as part of a normal hair growth cycle. It’s average for a healthy person to lose around 100 strands of hair a day. Usually, hair loss grows back, and people can maintain a full head of hair. However, various illnesses, stress, hormonal changes, aging, tight hairstyles, perms or bleaching, and inherited conditions can affect a hair growth cycle. These conditions can cause hair to fall but prevent it from growing back.

Men, women, and even children can experience hair loss. It can be emotionally difficult to lose hair, whether temporary or permanent. Hair can significantly impact one’s self-esteem.

The most typical types of hair loss are Androgenic alopecia, Alopecia areata, Telogen effluvium, and Anagen effluvium. Treatment plans can vary, including medication, hair transplants, or platelet-rich plasma.

Segments of Empowered are developed through a quality-controlled and collaborative creative process. The Empowered team of creators utilizes their cumulative decades of experience to create unique and informational content. The Empowered program is developed for educational purposes and is made for distribution for multiple networks. Each episode is created using advanced filming techniques and technologies.

Share article on social media or email: